Bronchoalveolar Fluid and Plasma Inflammatory Biomarkers in Contemporary ARDS Patients.

CONCLUSIONS: Baseline biomarker levels in current ARDS patients are substantially lower than 6-20 years before collection of these samples. These findings, whether from ICU care changes resulting in less inflammation or from variation in assay techniques over time, have important implications for design of future RCTs with biomarkers as endpoints. PMID: 30744430 [PubMed - as supplied by publisher]
Source: Biomarkers - Category: Research Tags: Biomarkers Source Type: research